Characteristics | uOR | 95% CI | aOR | 95% CI | p value* |
---|---|---|---|---|---|
Pre-existing chronic conditions | Ìý | Ìý | Ìý | Ìý | Ìý |
 chronic lung disease | 2.39 | (1.65, 3.45) | 1.64 | (1.08, 2.47) | 0.020 |
 sleep apnea | 1.42 | (1.14, 1.76) | 1.18 | (0.93, 1.49) | 0.180 |
 a²õ³Ù³ó³¾²¹ | 1.59 | (1.30, 1.96) | 1.22 | (0.98, 1.52) | 0.075 |
 chronic heart disease | 1.16 | (0.83, 1.64) | 0.76 | (0.52, 1.12) | 0.166 |
 d¾±²¹²ú±ð³Ù±ð²õ | 1.12 | (0.85, 1.46) | 0.89 | (0.66, 1.19) | 0.431 |
 chronic kidney disease | 1.13 | (0.71, 1.80) | 0.96 | (0.54, 1.69) | 0.882 |
 high blood pressure | 1.36 | (1.17, 1.60) | 1.32 | (1.11, 1.58) | 0.002 |
 chronic blood disorder | 1.19 | (0.59, 2.40) | 0.65 | (0.30, 1.43) | 0.286 |
 o²õ³Ù±ð´Ç±è´Ç°ù´Ç²õ¾±²õ | 1.08 | (0.71, 1.63) | 0.59 | (0.39, 0.89) | 0.012 |
 back problems | 1.63 | (1.37, 1.95) | 1.12 | (0.92, 1.38) | 0.266 |
 urinary incontinence | 1.30 | (0.94, 1.80) | 0.90 | (0.63, 1.26) | 0.525 |
 bowel disorder | 1.68 | (1.27, 2.23) | 1.08 | (0.82, 1.42) | 0.599 |
 weakened immune system | 2.37 | (1.77, 3.16) | 1.48 | (1.08, 2.02) | 0.014 |
 chronic neurological disorder | 1.71 | (1.09, 2.70) | 0.93 | (0.59, 1.48) | 0.760 |
 chronic fatigue syndrome or fibromyalgia | 4.57 | (3.00, 6.97) | 2.12 | (1.34, 3.36) | 0.001 |
 s³Ù°ù´Ç°ì±ð | 1.06 | (0.58, 1.94) | 0.78 | (0.40, 1.51) | 0.454 |
 mental health condition | 1.64 | (1.39, 1.94) | 1.10 | (0.91, 1.32) | 0.326 |
 a°ù³Ù³ó°ù¾±³Ù¾±²õ | 1.70 | (1.44, 2.00) | 1.24 | (1.01, 1.52) | 0.044 |
Age at infection (ref = 15–34) | - | - | - | - | &±ô³Ù; 0.001 |
 35–49 | 1.02 | (0.90, 1.16) | 1.04 | (0.91, 1.19) | 0.559 |
 50–64 | 1.10 | (0.96, 1.26) | 0.96 | (0.83, 1.12) | 0.628 |
 65+ | 0.87 | (0.74, 1.02) | 0.67 | (0.55, 0.83) | &±ô³Ù; 0.001 |
Sex (ref = male) | - | - | - | - | &±ô³Ù; 0.001 |
 f±ð³¾²¹±ô±ð | 1.44 | (1.29, 1.60) | 1.31 | (1.16, 1.47) | &±ô³Ù; 0.001 |
Ethnicity (ref = white) | - | - | - | - | 0.023 |
 I²Ô»å¾±²µ±ð²Ô´Ç³Ü²õ | 1.26 | (0.97, 1.64) | 1.14 | (0.87, 1.50) | 0.338 |
 South Asian | 0.97 | (0.71, 1.32) | 0.93 | (0.66, 1.29) | 0.648 |
 East/Southeast Asian | 0.64 | (0.51, 0.80) | 0.62 | (0.49, 0.79) | &±ô³Ù; 0.001 |
 B±ô²¹³¦°ì | 0.90 | (0.57, 1.44) | 0.81 | (0.50, 1.32) | 0.400 |
 Arab/West Asian | 0.73 | (0.48, 1.10) | 0.72 | (0.46, 1.13) | 0.152 |
 Latin American | 0.87 | (0.56, 1.34) | 0.89 | (0.57, 1.37) | 0.582 |
 M¾±³æ±ð»å/°¿³Ù³ó±ð°ù | 1.09 | (0.80, 1.47) | 1.09 | (0.79, 1.51) | 0.597 |
Ethno-cultural composition (ref = first quintile)a | - | - | - | - | 0.002 |
 s±ð³¦´Ç²Ô»å | 1.27 | (1.07, 1.51) | 1.25 | (1.04, 1.51) | 0.016 |
 t³ó¾±°ù»å | 1.21 | (1.03, 1.42) | 1.19 | (1.00, 1.42) | 0.052 |
 f´Ç³Ü°ù³Ù³ó | 1.40 | (1.19, 1.64) | 1.43 | (1.20, 1.70) | &±ô³Ù; 0.001 |
 fifth (highest) | 1.20 | (0.99, 1.44) | 1.39 | (1.13, 1.71) | 0.002 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.37 | (1.11, 1.70) | 1.44 | (1.12, 1.87) | 0.005 |
Situational vulnerability (ref = first quintile)b | - | - | - | - | 0.001 |
 s±ð³¦´Ç²Ô»å | 0.96 | (0.82, 1.13) | 0.97 | (0.82, 1.15) | 0.716 |
 t³ó¾±°ù»å | 1.02 | (0.87, 1.19) | 0.95 | (0.80, 1.12) | 0.517 |
 f´Ç³Ü°ù³Ù³ó | 1.06 | (0.90, 1.25) | 0.98 | (0.82, 1.17) | 0.851 |
 fifth (highest) | 0.78 | (0.65, 0.93) | 0.68 | (0.56, 0.82) | &±ô³Ù; 0.001 |
 u²Ô°ì²Ô´Ç·É²Ôc | 1.09 | (0.89, 1.33) | - | - | - |
Pre-existing chronic health symptoms | Ìý | Ìý | Ìý | Ìý | Ìý |
 symptoms relating to the heart | 1.94 | (1.53, 2.47) | 1.33 | (1.01, 1.75) | 0.039 |
 loss of appetite | 3.08 | (1.94, 4.89) | 1.80 | (1.11, 2.92) | 0.017 |
Number of pre-existing chronic health symptoms (ref = 0) | - | - | - | - | &±ô³Ù; 0.001 |
 1 or 2 | 1.29 | (1.11, 1.47) | 1.21 | (1.06, 1.39) | 0.005 |
 3 | 1.74 | (1.43, 2.11) | 1.64 | (1.33, 2.03) | &±ô³Ù; 0.001 |
 &²µ³Ù; 3 | 2.21 | (1.92, 2.54) | 1.60 | (1.32, 1.93) | &±ô³Ù; 0.001 |
Months since last vaccine dose prior to the month of infection (ref = 3 months or less) | - | - | - | - | &±ô³Ù; 0.001 |
 not vaccinated | 1.96 | (1.67, 2.30) | 1.49 | (1.14, 1.93) | 0.003 |
 4–6 months | 1.23 | (1.08, 1.40) | 1.33 | (1.16, 1.51) | &±ô³Ù; 0.001 |
 > 6 months | 1.22 | (1.02, 1.46) | 1.28 | (1.06, 1.54) | 0.009 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.11 | (0.76, 1.61) | 1.04 | (0.72, 1.50) | 0.822 |
Time period of first infection (ref = pre-omicron) | - | - | - | - | 0.004 |
 Omicron (December 1, 2021 – date of electronic questionnaire completion) | 0.57 | (0.50, 0.66) | 0.67 | (0.53, 0.87) | 0.002 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.14 | (0.42, 3.11) | 1.48 | (0.50, 4.37) | 0.482 |
Household member testing positive for SARS-CoV-2 infection (ref = no) | - | - | - | - | 0.001 |
 y±ð²õ | 0.76 | (0.68, 0.85) | 0.84 | (0.74, 0.94) | 0.004 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.42 | (0.73, 2.77) | 1.77 | (0.90, 3.49) | 0.099 |